Original Research
Published on 11 Feb 2026
Real-world experience of Dolutegravir/Lamivudine for rapid initiation of antiretroviral therapy among treatment-naïve HIV-1-infected adults in China: a multicenter retrospective study
in Infectious Diseases: Pathogenesis and Therapy
- 325 views